IQuity Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

IQuity General Information

Description

Operator of a genomics platform designed to detect and monitor chronic diseases starting with autoimmune conditions. The company's technology leds blood tests using ribonucleic acid data to accurately identify autoimmune disease earlier than current and conventional testing methodologies, enabling researchers to shorten the diagnostic process for autoimmune disease and related conditions.

Contact Information

Website
iquitylabs.com
Formerly Known As
Ichor Biotechnologies, IQuity Labs, Ichor Biotechnologies, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • 111 10th Avenue South
  • Suite 100
  • Nashville, TN 37203
  • United States
+1 (615) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IQuity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Aug-2021 00.00 Completed Generating Revenue
9. Grant 01-Jan-2020 000000 00.00 Completed Generating Revenue
8. Grant 01-Sep-2019 00.000 00.00 Completed Generating Revenue
7. Grant 01-Jan-2018 00.000 00.00 Completed Generating Revenue
6. Angel (individual) 06-Apr-2018 00.000 00.00 Completed Generating Revenue
5. Seed Round 17-May-2017 00.000 00.000 000.00 Completed Generating Revenue
4. Grant 02-Jan-2017 00.000 000 Completed Product Development
3. Grant 01-Jan-2017 00.000 000 Completed Generating Revenue
2. Seed Round 18-Mar-2016 $2M $2M 000 Completed Product Development
1. Grant 01-Jan-2016 $160K Completed Product Development
To view IQuity’s complete valuation and funding history, request access »

IQuity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2 (cash) 000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed-2 (note) 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 515,000 $0.000100 $0.28 $4 $4 1x $4 25.06%
To view IQuity’s complete cap table history, request access »

IQuity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a genomics platform designed to detect and monitor chronic diseases starting with autoimmune conditions. The
Biotechnology
Nashville, TN
3 As of 2022
00.00
000000&0 00.00

00000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000000
Aliso Viejo, CA
000 As of 0000
000 0000-00-00
000000&0

000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000 00000000
Vista, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IQuity Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Corporate Backed or Acquired Aliso Viejo, CA 000 000000&0
Exagen Formerly VC-backed Vista, CA 000 00000 000000000 00000
Myriad Genetics Corporation Salt Lake City, UT 0000 00000 00000000 00000
Genomic Expression Venture Capital-Backed Beverly, MA 00 00.00 00000 00000
Qvella Venture Capital-Backed Richmond Hill, Canada 00 000.00 000000 - 000 000.00
You’re viewing 5 of 17 competitors. Get the full list »

IQuity Patents

IQuity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10982259-B2 Long non-coding rna gene expression signatures in disease monitoring and treatment Active 05-Oct-2017 0000000000 0
US-20190119730-A1 Long non-coding rna gene expression signatures in disease monitoring and treatment Active 05-Oct-2017 0000000000
US-20190108915-A1 Disease monitoring from insurance claims data Inactive 05-Oct-2017 000000000 0
US-20240029892-A1 Disease monitoring from insurance claims data Pending 05-Oct-2017 G16H50/30 0

IQuity Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IQuity Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government Minority 000 0000 000000 0
To view IQuity’s complete investors history, request access »

IQuity FAQs

  • When was IQuity founded?

    IQuity was founded in 2015.

  • Who is the founder of IQuity?

    Charles Spurlock Ph.D, Julia Polk, and Thomas Aune Ph.D are the founders of IQuity.

  • Where is IQuity headquartered?

    IQuity is headquartered in Nashville, TN.

  • What is the size of IQuity?

    IQuity has 3 total employees.

  • What industry is IQuity in?

    IQuity’s primary industry is Biotechnology.

  • Is IQuity a private or public company?

    IQuity is a Private company.

  • What is IQuity’s current revenue?

    The current revenue for IQuity is 00000.

  • How much funding has IQuity raised over time?

    IQuity has raised $5.8M.

  • Who are IQuity’s investors?

    National Institute Of Allergy and Infectious Diseases, National Institutes of Health, and U.S. Department of Health and Human Services have invested in IQuity.

  • Who are IQuity’s competitors?

    Ambry Genetics, Exagen, Myriad Genetics, Genomic Expression, and Qvella are some of the 17 competitors of IQuity.

  • When was IQuity acquired?

    IQuity was acquired on 01-Aug-2021.

  • Who acquired IQuity?

    IQuity was acquired by Decode Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »